Journal of Surgery Concepts & Practice ›› 2020, Vol. 25 ›› Issue (01): 79-82.doi: 10.16139/j.1007-9610.2020.01.018
• Review • Previous Articles Next Articles
HAN Tonglei, SUN Yudong, WEI Xiaolong, ZHAO Zhiqing(
), JING Zaiping
Received:2019-04-30
Online:2020-01-25
Published:2020-02-25
Contact:
ZHAO Zhiqing
E-mail:zhaozqxueguan@126.com
CLC Number:
HAN Tonglei, SUN Yudong, WEI Xiaolong, ZHAO Zhiqing, JING Zaiping. New advance in treatment of Takayasu arteritis[J]. Journal of Surgery Concepts & Practice, 2020, 25(01): 79-82.
| [22] |
Salvarani C, Hatemi G. Management of large-vessel vasculitis[J]. Curr Opin Rheumatol, 2019, 31(1):25-31.
doi: 10.1097/BOR.0000000000000561 pmid: 30461542 |
| [23] | Muratore F, Pipitone N, Salvarani C. Standard and biolo-gical treatment in large vessel vasculitis: guidelines and current approaches[J]. Expert Rev Clin Immunol, 2017, 13(4):345-360. |
| [24] |
Ferfar Y, Mirault T, Desbois AC, et al. Biotherapies in large vessel vasculitis[J]. Autoimmun Rev, 2016, 15(6):544-551.
doi: 10.1016/j.autrev.2016.02.012 pmid: 26883459 |
| [25] |
De Franciscis S, Serra R, Luongo A, et al. The management of Takayasu's arteritis: personal experience[J]. Ann Vasc Surg, 2007, 21(6):754-760.
pmid: 17512164 |
| [26] | Keser G, Aksu K. What is new in management of Takayasu arteritis?[J]. Presse Med, 2017, 46(7-8 Pt 2):e229-e235. |
| [27] |
Mekinian A, Comarmond C, Resche-Rigon M, et al. Efficacy of biological-targeted treatments in Takayasu arteritis: multicenter, retrospective study of 49 patients[J]. Circulation, 2015, 132(18):1693-1700.
doi: 10.1161/CIRCULATIONAHA.114.014321 pmid: 26354797 |
| [28] |
Novikov PI, Smitienko IO, Sokolova MV, et al. Certolizumab pegol in the treatment of Takayasu arteritis[J]. Rheumatology (Oxford), 2018, 57(12):2101-2105.
doi: 10.1093/rheumatology/key197 pmid: 30010945 |
| [29] |
Gudbrandsson B, Molberg O, Palm O. TNF inhibitors appear to inhibit disease progression and improve outcome in Takayasu arteritis; an observational, population-based time trend study[J]. Arthritis Res Ther, 2017, 19(1):99.
doi: 10.1186/s13075-017-1316-y pmid: 28521841 |
| [30] |
Schmidt J, Kermani TA, Bacani AK, et al. Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup[J]. Arthritis Care Res (Hoboken), 2012, 64(7):1079-1083.
doi: 10.1002/acr.21636 pmid: 22328491 |
| [31] |
Molloy ES, Langford CA, Clark TM, et al. Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up[J]. Ann Rheum Dis, 2008, 67(11):1567-1569.
doi: 10.1136/ard.2008.093260 pmid: 18677012 |
| [32] | Lee YH, Song GG. Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis[J]. Ann Rheum Dis, 2019, 78(1):e9. |
| [33] | Loricera J, Blanco R, Hernandez JL, et al. Tocilizumab in patients with Takayasu arteritis: a retrospective study and literature review[J]. Clin Exp Rheumatol, 2016, 34(3 Suppl 97):S44-S53. |
| [34] | Risse J, Mandry D, Settembre N, et al. Dramatic response to tocilizumab before emergency surgery in severe active Takayasu disease[J]. Circ Cardiovasc Imaging, 2016, 9(7).pii: e004819. |
| [35] | Nesher G, Berkun Y, Mates M, et al. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis[J]. Arthritis Rheum, 2004, 50(4):1332-1337. |
| [36] | Langford CA, Cuthbertson D, Ytterberg SR, et al. A randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of Takayasu arteritis[J]. Arthritis Rheumatol, 2017, 69(4):846-853. |
| [37] | Li J, Zhu M, Li M, et al. Cause of death in Chinese Takayasu arteritis patients[J]. Medicine (Baltimore), 2016, 95(27):e4069. |
| [38] | Lee BB. Simultaneous multiple bypass for Takayasu arteritis[J]. Eur J Vasc Endovasc Surg, 2018, 56(6):910. |
| [39] | Chen ZG, Chen YX, Diao YP, et al. Simultaneous multi-supra-aortic artery bypass successfully implemented in 17 patients with type Ⅰ Takayasu arteritis[J]. Eur J Vasc Endovasc Surg, 2018, 56(6):903-909. |
| [40] | 冯睿, 魏小龙, 赵志青, 等. 采用单条大隐静脉行腹主动脉-双侧肾动脉旁路术治疗大动脉炎性肾动脉狭窄[J]. 外科理论与实践, 2011, 16(2):151-154. |
| [41] | Kim YW, Kim DI, Park YJ, et al. Surgical bypass vs. endovascular treatment for patients with supra-aortic arterial occlusive disease due to Takayasu arteritis[J]. J Vasc Surg, 2012, 55(3):693-700. |
| [42] | Mason JC. Surgical intervention and its role in Takayasu arteritis[J]. Best Pract Res Clin Rheumatol, 2018, 32(1):112-124. |
| [43] |
Schmidt J, Kermani TA, Bacani AK, et al. Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients[J]. Mayo Clin Proc, 2013, 88(8):822-830.
doi: 10.1016/j.mayocp.2013.04.025 pmid: 23849994 |
| [44] | Che W, Xiong H, Jiang X, et al. Stenting for middle aortic syndrome caused by Takayasu arteritis-immediate and long-term outcomes[J]. Catheter Cardiovasc Interv, 2018, 91(S1):623-631. |
| [45] |
Hadjadj J, Canaud G, Mirault T, et al. mTOR pathway is activated in endothelial cells from patients with Takayasu arteritis and is modulated by serum immunoglobulin G[J]. Rheumatology (Oxford), 2018, 57(6):1011-1020.
doi: 10.1093/rheumatology/key017 pmid: 29506143 |
| [46] | Saleh HM, Gabr AK, Tawfik MM, et al. Prospective, randomized study of cutting balloon angioplasty versus conventional balloon angioplasty for the treatment of hemodialysis access stenoses[J]. J Vasc Surg, 2014, 60(3):735-740. |
| [47] | Gumus B, Cevik H, Vuran C, et al. Cutting balloon angioplasty of bilateral renal artery stenosis due to Takayasu arteritis in a 5-year-old child with midterm follow-up[J]. Cardiovasc Intervent Radiol, 2010, 33(2):394-397. |
| [1] | Mirouse A, Biard L, Comarmond C, et al. Overall survival and mortality risk factors in Takayasu's arteritis: A multicenter study of 318 patients[J]. J Autoimmun, 2019, 96(1):35-39. |
| [2] |
Xiao Y, Zhou J, Wei X, et al. Outcomes of different treatments on Takayasu's arteritis[J]. J Thorac Dis, 2016, 8(9):2495-2503.
pmid: 27747001 |
| [3] | De Souza AW, De Carvalho JF. Diagnostic and classification criteria of Takayasu arteritis[J]. J Autoimmun, 2014, 48(2):79-83. |
| [4] |
Janarthanan M, Rathinasamy J. Aortic calcification in longstanding, undiagnosed Takayasu arteritis[J]. Lancet, 2018, 392(10151):950.
doi: S0140-6736(18)31997-4 pmid: 30238890 |
| [5] | Gomez L, Chaumet-Riffaud P, Noel N, et al. Effect of CRP value on F-FDG PET vascular positivity in Takayasu arteritis: a systematic review and per-patient based meta-analysis[J]. Eur J Nucl Med Mol Imaging, 2018, 45(4):575-581. |
| [6] |
Comarmond C, Biard L, Lambert M, et al. Long-term outcomes and prognostic factors of complications in Takayasu arteritis: a multicenter study of 318 patients[J]. Circulation, 2017, 136(12):1114-1122.
doi: 10.1161/CIRCULATIONAHA.116.027094 pmid: 28701469 |
| [7] | Park SJ, Kim HJ, Park H, et al. Incidence, prevalence, mortality and causes of death in Takayasu Arteritis in Korea - A nationwide, population-based study[J]. Int J Cardiol, 2017, 235(5):100-104. |
| [8] |
Gudbrandsson B, Molberg O, Garen T, et al. Prevalence, incidence, and disease characteristics of Takayasu arteritis by ethnic background: data from a large, population-based cohort resident in southern norway[J]. Arthritis Care Res (Hoboken), 2017, 69(2):278-285.
doi: 10.1002/acr.22931 pmid: 27159262 |
| [9] | Hong C, Zeng T, Zhao J, et al. Takayasu's arteritis misdiagnosed as mediastinal malignant lymphoma: a case report and review of the literature[J]. J Thorac Dis, 2014, 6(6):E115-E119. |
| [10] |
Aeschlimann FA, Barra L, Alsolaimani R, et al. Presentation and disease course of childhood-onset versus adult-onset Takayasu arteritis[J]. Arthritis Rheumatol, 2019, 71(2):315-323.
doi: 10.1002/art.40690 |
| [11] |
Watanabe Y, Miyata T, Tanemoto K. Current clinical features of new patients with Takayasu arteritis observed from cross-country research in japan: age and sex specificity[J]. Circulation, 2015, 132(18):1701-1709.
doi: 10.1161/CIRCULATIONAHA.114.012547 pmid: 26354799 |
| [12] |
Mwipatayi BP, Jeffery PC, Beningfield SJ, et al. Takayasu arteritis: clinical features and management: report of 272 cases[J]. ANZ J Surg, 2005, 75(3):110-117.
pmid: 15777385 |
| [13] | Tyagi S, Bansal A, Gupta MD, et al. Endovascular ma-nagement of acute aortic dissection in Takayasu arteritis[J]. JACC Cardiovasc Interv, 2018, 11(12):e99-e101. |
| [14] |
Park EH, Lee EY, Lee YJ, et al. Infliximab biosimilar CT-P13 therapy in patients with Takayasu arteritis with low dose of glucocorticoids: a prospective single-arm study[J]. Rheumatol Int, 2018, 38(12):2233-2242.
doi: 10.1007/s00296-018-4159-1 pmid: 30229280 |
| [15] | Goel R, Sathish KT, Danda D. Childhood-onset Takayasu arteritis (c-ta): current and future drug therapy[J]. Paediatr Drugs, 2019, 21(2):81-93. |
| [16] | Misra DP, Wakhlu A, Agarwal V, et al. Recent advances in the management of Takayasu arteritis[J]. Int J Rheum Dis, 2019, 22(1):60-68. |
| [17] | Samson M, Espigol-Frigole G, Terrades-Garcia N, et al. Biological treatments in giant cell arteritis & Takayasu arteritis[J]. Eur J Intern Med, 2018, 50(4):12-19. |
| [18] |
Decker P, Olivier P, Risse J, et al. Tocilizumab and refractory Takayasu disease: Four case reports and syste-matic review[J]. Autoimmun Rev, 2018, 17(4):353-360.
doi: S1568-9972(18)30034-X pmid: 29427826 |
| [19] | Sanchez-Alvarez C, Koster M, Duarte-García A, et al. Disease progression of Takayasu arteritis in two patients treated with tocilizumab[J]. Ann Rheum Dis, 2018-12-08[Epub ahead of print]. |
| [20] | Kong X, Zhang X, Lv P, et al. Treatment of Takayasu arteritis with the IL-6R antibody tocilizumab vs. cyclophosphamide[J]. Int J Cardiol, 2018, 266(9):222-228. |
| [48] | Tyagi S, Sarkar PG, Gupta MD, et al. Restoration of vision by endovascular revascularization in Takayasu arteritis: A case series[J]. J Cardiol Cases, 2018, 18(4):123-127. |
| [21] | Mekinian A, Resche-Rigon M, Comarmond C, et al. Efficacy of tocilizumab in Takayasu arteritis: Multicenter retrospective study of 46 patients[J]. J Autoimmun, 2018, 91(7):55-60. |
| [1] | AIKEBAIER Aniwaer, FENG Rui, FENG Jiaxuan, WU Mingwei, ZHAO Yuxi, JING Zaiping. Analysis of factors influencing endoleak following endovascular repair using parallel stent technique for thoracic and abdominal aortic dilatation [J]. Journal of Surgery Concepts & Practice, 2020, 25(02): 146-151. |
| [2] | BAO Yingjun, GU Junpeng, ZHANG Haixiao, ZHU Diwen, REN Weixin. Efficacy of transjugular intrahepatic portosystemic shunt in treatment of portal hypertension: A comparison of Viatorr stent and covered stent combined with bare (metal) stent [J]. Journal of Surgery Concepts & Practice, 2019, 24(06): 517-521. |
| [3] | . [J]. Journal of Surgery Concepts & Practice, 2019, 24(04): 289-292. |
| [4] | . [J]. Journal of Surgery Concepts & Practice, 2019, 24(04): 293-296. |
| [5] | . [J]. Journal of Surgery Concepts & Practice, 2019, 24(04): 362-366. |
| [6] | . [J]. Journal of Surgery Concepts & Practice, 2019, 24(04): 285-288. |
| [7] | . [J]. Journal of Surgery Concepts & Practice, 2019, 24(04): 297-300. |
| [8] | . [J]. Journal of Surgery Concepts & Practice, 2019, 24(04): 301-303. |
| [9] | . [J]. Journal of Surgery Concepts & Practice, 2019, 24(04): 304-306. |
| [10] | . [J]. Journal of Surgery Concepts & Practice, 2019, 24(04): 307-310. |
| [11] | LIU Zhen, ZHANG Guodong, ZHANG Tao, LI Cheng, JI Donghua. Combination of Rotarex debulking with drug coated balloon in treatment of superficial femoral artery in-stent restenosis [J]. Journal of Surgery Concepts & Practice, 2019, 24(04): 311-314. |
| [12] | HAN Tonglei, WANG Shiying, SUN Yudong, WEI Xiaolong, ZHU Jiang, LU Minhao, ZHAO Bin, ZHAO Zhiqing, JING Zaiping. Severe stenosis and more severe stenosis of carotid artery: treatment strategies and complications [J]. Journal of Surgery Concepts & Practice, 2019, 24(04): 315-319. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
